spironolactone has been researched along with Exanthema in 1 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Exanthema: Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Le-Rademacher, JG | 1 |
Rowland, K | 1 |
Atherton, PJ | 1 |
Dakhil, C | 1 |
Sun, Z | 1 |
Tan, A | 1 |
Schmidt, L | 1 |
Nguyen, PL | 1 |
Radecki Breitkopf, C | 1 |
Pittelkow, M | 1 |
Tindall, D | 1 |
Menon, S | 1 |
Jatoi, A | 1 |
1 trial available for spironolactone and Exanthema
Article | Year |
---|---|
Androgen Mediation-and Antiandrogens Mitigation-of the Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series.
Topics: Adult; Aged; Androgen Antagonists; Biopsy; Double-Blind Method; ErbB Receptors; Exanthema; Female; H | 2019 |